HPSI0416i-iooi_1

General

Cell Line

hPSCreg name WTSIi514-A
Cite as:
WTSIi514-A (RRID:CVCL_IX57)
Alternative name(s)
HPSI0416i-iooi_1
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
WTSIi514-B
(HPSI0416i-iooi_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
ICANi001-A-1
(CDGEN1.16.40.5)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-1
(Rep 28, Iso Co)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-2
(Bi-allelic mutant, Mut 103)
Donor diseases:
hypertrophic cardiomyopathy
WTSIi461-B
(HPSI0316i-eoko_3)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi461-A
(HPSI0316i-eoko_5)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi462-A
(HPSI0316i-miov_1)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi679-B
(HPSI0316i-ponl_4)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi685-B
(HPSI0416i-ioys_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi493-B
(HPSI0416i-ruah_5)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi460-B
(HPSI0516i-jepf_3)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi679-A
(HPSI0316i-ponl_2)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi685-A
(HPSI0416i-ioys_5)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi460-A
(HPSI0516i-jepf_5)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi493-A
(HPSI0416i-ruah_4)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi499-A
(HPSI0416i-xutl_2)
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-A
(NP0138-8B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-B
(NP0138-19E)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-C
(NP0138-31B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi929-A
(CW30245)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi965-A
(CW30288)
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi025-A
(NP0135-1)
Donor's gene variants:
MYH7
Donor diseases:
Rare hypertrophic cardiomyopathy
IBBISTi006-A
(F93 clone 5)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi017-B
(NP0075-10K)
Donor diseases:
Rare hypertrophic cardiomyopathy
IBBISTi006-B
(F93 clone 6)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi017-C
(NP0075-11B)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi726-A
(CW30001)
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi025-B
(NP0135-2)
Donor's gene variants:
MYH7
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi025-C
(NP0135-7)
Donor's gene variants:
MYH7
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi731-A
(CW30006)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi736-A
(CW30011)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi741-A
(CW30017)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi742-A
(CW30018)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi744-A
(CW30020)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi752-A
(CW30032)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00O-A
(CW30346)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi770-A
(CW30054)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi771-A
(CW30055)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi01B-A
(CW30362)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi074-A
(SCVIi599C1)
Donor's gene variants:
BAG cochaperone 3
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi779-A
(CW30064)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi781-A
(CW30067)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi793-A
(CW30080)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi797-A
(CW30084)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi823-A
(CW30115)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi835-A
(CW30133)
Donor diseases:
Hypertrophic Cardiomyopathy
Last update 22nd May 2019
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Wellcome Sanger Institute (WTSI)
Distributors

External Databases

HipSci HPSI0416i-iooi_1
BioSamples SAMEA4562345
Cellosaurus CVCL_IX57
Wikidata Q54890758

General Information

Projects
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex female
Age of donor (at collection) 75-79
Ethnicity Caucasian

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA4447176

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Please provide contact information of the holder of the original Donor Information Sheet.
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? No
Please provide the contact information
Alternatives to consent
Alternative consent approval number
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Details on restriction to research project
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed?
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Please describe how access is provided:
Contact data, institution, or website:
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? No
Name of accrediting authority involved?
Approval number
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Hampstead Research Ethics Committee
Approval number 13/LO/0171
Please describe:
Further constraints on use
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Constraints for use or distribution

hIPSC Derivation

General

Source cell type
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
Source cell origin
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
Synonyms
  • portion of skin
  • region of skin
  • skin
  • skin region
  • skin zone
show more synonyms
Age of donor (at collection) 75-79
Collected in 2016
Source cell line vendor University College London

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Notes on reprogramming vector detection CytoTune 2

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Vitronectin
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
CO2 Concentration 5 %
Medium TeSR™ E8™

Characterisation

Analysis of Undifferentiated Cells
Pluripotency Score Novelty Score
3.494 1.634

Certificate of Analysis

Is there a certificate of analysis available?
Yes

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
No

Other Genotyping (Cell Line)

Is there genome-wide genotyping or functional data available?
Yes
cnv
http://www.hipsci.org/lines/#/lines/HPSI0416i-iooi_1
Number of regions different from primary tissue: 0; Length of differences from primary tissue: 0
Exome sequencing
https://ega-archive.org/datasets/EGAD00001003523
BWA alignment
Exome sequencing
https://ega-archive.org/datasets/EGAD00001003523
Raw sequencing reads
Exome sequencing
https://ega-archive.org/datasets/EGAD00001003523
mpileup variant calls
RNA-seq
https://ega-archive.org/datasets/EGAD00001003540
Abundances of transcripts
RNA-seq
https://ega-archive.org/datasets/EGAD00001003540
Splice-aware STAR alignment